Abramson JS, Kamdar M, Liu FF, Crotta A, et al. Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphoma. Leuk Lymphoma 2025 Jul 24:1-14. doi: 10.1080/10428194.2025.2532674.
PMID: 40708270